The Bhubaneswar-based CureBay has acquired the pharmaceutical distribution business of Saveo Healthtech officially. This strategic acquisition will be a turning point in the history of CureBay since it aims to strengthen its supply chain and improve the provision of healthcare services to underserved areas.

Combining the proven distribution capabilities of Saveo, CureBay is on the brink of bridging the communication divide between the medical appointment and actual delivery of genuine medications, especially in the rural setting, where the issue of availability to high-quality pharmaceutical products is a systemic problem.

Core motivation and operational framework

The acquisition is a targeted cultural asset acquisition that conforms to the main objective of CureBay, which is to offer the full scope of healthcare solutions at the grassroots level. Saveo Healthtech is a Bengaluru-based organization that has been serving as a niche B2B e-commerce platform with the aim of simplifying the procurement exercise of local pharmacies.

Offloading its distribution arm to CureBay allows establishing a synergy in which the logistics and supply network of Saveo can be reused to the benefit of CureBay and its expanding network of e-clinics. This integration will lead to the high reduction in lead time to deliver medicine and a higher level of quality control throughout the value chain.

The core motivation of this purchase is the fact that CureBay wants to ensure a strong and stable supply of drugs to its patients. Priyadarshi Mohapatra, Shobhan Mahapatra, and Sanjay Parchure founded the startup in 2021, and the company has been working on creating a hybrid healthcare model.

This model involves the use of a network of e-clinics in small towns and villages, which serve as physical points of contact where the patient is able to receive a digital consultation with a specialty doctor. The consultation itself is useless without the follow-up treatment, and the decision to purchase the distribution business of Saveo will provide access to the prescribed “authentic medicines” which might otherwise be too far away for the patient to reach a reliable pharmacy.

The acquisition of the distribution infrastructure will put CureBay directly in control of the inventory and the logistics that the company had previously controlled by Saveo. The change is especially significant to address the complications of rural logistics, where fragmented supply chains can result in stockouts or the development of sub-standard medications.

The knowledge base of the two organizations would result in a stronger infrastructure, in which CureBay can use the technical and operational infrastructure provided by Saveo in order to expand its operations further. This strategic expansion of the supply chain is a definite sign of CureBay being focused on offering a holistic and end-to-end healthcare experience to its users.

Acquisition and strategic scaling

The purchase unites the ideals of two different groups of innovators in the Indian startup realm. CureBay, under the leadership of its three founders. It is currently an established brand in the Odisha area and outside due to its attention to healthcare accessibility.

Central to its operations is its headquarters in Bhubaneswar, which acts as the umbilical point of its operations that bridge the gap between urban medical knowledge and patient requirements in the countryside. The focus on quality of governance and strict performance has been an attribute of the company since its inception and has enabled it to navigate through the highly regulated and logistically challenging pharmaceutical environment.

Saveo Healthtech, which was on the other side of the deal, was founded by Vivek Jaiswal, Anurag Gupta, Shivansh Shrivastava, and Amit Kumar. Founded in Bengaluru, the tech metropolis, Saveo was developed to modernize the ancient ecosystem of pharmacy by offering a digital market to manage inventory and purchases.

Although Saveo has traditionally concentrated in the B2B sector of the industry, its distribution competencies are currently being made an essential part of the consumer-based rural healthcare of CureBay. Such asset transfer is indicative of a current trend in the startup industry, which is the consolidation of specialized vertical knowledge into more holistic service providers.

Venture capital support has provided the company with a strong foundation to support the acquisition. CureBay has proven to be an investor with high confidence, and the recent fundraiser of approximately $10.2 million during an extension round led by Elevar Equity in early 2024 indicates it has high investor confidence.

This capital raised the total amount of capital raised by the company to approximately $19 million. This kind of huge financial support has given the company the liquidity it needs to make strategic acquisitions such as the Saveo distribution business, which involves capital to regulate inventory and the maintenance of logistics networks.

Saveo itself has suffered a good track record of successful fundraising, with it having raised approximately $4 million in its seed round in 2021. These companies attracting capital are indicative of the enormous potential of the Indian healthtech market, especially in those segments that target the missing middle and underserved rural population.

In the case of CureBay, the existing acquisition not only expands its assets but also its operational capacity in line with the demands of its growing e-clinic network. The expansion of the global geographical regions of the company will rely heavily on the integration of the distribution arm of Saveo as the company keeps expanding.

Conclusion

The cognitive purchase of the pharmaceutical distribution business of Saveo by CureBay is a complex move in solving the intricate mystery of rural healthcare provision in India. Combining digital consultation services with a highly effective, physical supply chain, CureBay is literally eliminating the barriers that had previously denied rural patients access to timely and genuine medical care.

With CureBay becoming the owner of the operations of Saveo, the synergy that will be formed is set to make healthcare systems more efficient, transparent, and reliable to the millions of people who live in smaller towns and villages within India. The relocation not only puts CureBay in a stronger position in the market but also introduces the possibility of how a well-integrated supply chain can be used to make a social impact by deploying a commercial innovation.